Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
NCT Number: NCT06900465
The goal of this waitlist-controlled randomized pilot trial is to premilinariliy learn if the CPG-CA internvention, a group psychoeducational intervention for family caregivers of children and adolescents with emotional and behavioral disorders, works to relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China. It will also learn about the acceptability of the CPG-CA intervention. The main questions it aims to answer are:
Does the CPG-CA intervention relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China? Is the CPG-CA intervention acceptable to family caregivers of children and adolescents with emotional and behavioral disorders in China?
Researchers will compare the CPG-CA intervention to care-as-usual to see if the CPG-CA internvention works to relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China.
Participants will receive the CPG-CA intervention or care-as-usual for 12 weeks.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Shanghai, Shanghai Municipality, 200030, China
In China, most children and adolescents with emotional and behavioral disorders (E/BDs) are living with families. With an extreme scarcity of child and adolescent mental health care resources in China, the primary caregiving responsibility for children and adolescents with E/BDs is laid on families. However, caregiving for children and adolescents with E/BDs could be challenging, and family caregivers of children and adolescents with E/BDs often describe their caregiving experiences as exhausting and burdensome.
To date, very few interventions in China have been designed to relieve caregiver burden among family caregivers of children and adolescents with E/BDs. Therefore, this study aims to conduct a randomized, wait-list controlled pilot trial to preliminarily evaluate the feasibility and effectiveness of the CPG-CA intervention, a group psychoeducational intervention for family caregivers of children and adolescents with E/BDs, in reducing caregiver burden among family caregivers of children and adolescents with E/BDs in China. This pilot trial will lay the groundwork for a major trial that will be conducted in future studies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The CPG-CA intervention is a group psychoeducational internvention for family caregivers of children and adolescents with E/BDs in China. It will consist of 10 to 15 family caregivers of children and adolescents with E/BDs, meeting once a week for 1.5 to 2 hours per session, for a total of 12 sessions over a 3-month period. The sessions will cover the following themes: (1) knowledge about child and adolescent emotional and behavioral disorders; (2) coping skills for common emotional and behavioral problems in children and adolescents; (3) problem-solving skills; (4) communication skills with children and adolescents; (5) positive parenting techniques; and (6) self-care techniques. A variety of facilitation techniques will be used in the intervention, including didactic teaching, group discussion, role-playing, and homework assignment.
Time frame: Baseline (T0) and 3 months (T1)
Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).
Time frame: Baseline (T0) and 6 months (T2)
Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).
Time frame: Baseline (T0) and 9 months (T3)
Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).
Time frame: Baseline (T0) and 3 months (T1)
Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).
Time frame: Baseline (T0) and 6 months (T2)
Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).
Time frame: Baseline (T0) and 9 months (T3)
Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).
Time frame: Baseline (T0) and 3 months (T1)
Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).
Time frame: Baseline (T0) and 6 months (T2)
Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).
Time frame: Baseline (T0) and 9 months (T3)
Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).
Time frame: Baseline (T0) and 3 months (T1)
Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).
Time frame: Baseline (T0) and 6 months (T2)
Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).
Time frame: Baseline (T0) and 9 months (T3)
Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).
Time frame: Baseline (T0) and 3 months (T1)
Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).
Time frame: Baseline (T0) and 6 months (T2)
Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).
Time frame: Baseline (T0) and 9 months (T3)
Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).
Time frame: Baseline (T0) and 3 months (T1)
Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).
Time frame: Baseline (T0) and 6 months (T2)
Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).
Time frame: Baseline (T0) and 9 months (T3)
Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).
Time frame: Baseline (T0) and 3 months (T1)
Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).
Time frame: Baseline (T0) and 6 months (T2)
Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).
Time frame: Baseline (T0) and 9 months (T3)
Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).
Time frame: Baseline (T0) and 3 months (T1)
Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).
Time frame: Baseline (T0) and 6 months (T2)
Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).
Time frame: Baseline (T0) and 9 months (T3)
Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).
Time frame: Baseline (T0) and 3 months (T1)
Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).
Time frame: Baseline (T0) and 6 months (T2)
Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).
Time frame: Baseline (T0) and 9 months (T3)
Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).
Time frame: Baseline (T0) and 3 months (T1)
Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).
Time frame: Baseline (T0) and 6 months (T2)
Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).
Time frame: Baseline (T0) and 9 months (T2)
Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).
Contact information is provided by the study sponsor or research team.
Shanghai Mental Health Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735481
Chemically-Induced Disorders, Mental Disorders
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT07710456
Atrophy, Body Weight
View Trial DetailsNCT07708675
Alzheimer Disease, Alzheimer's
View Trial DetailsNCT07704762
Combat Disorders, Mental Disorders
View Trial Details